Q&A Distressed Private Debt & Private Equity
Hi Everybody MD / Head of Investments Private Debt & Private Equity - Distressed & Special Sits. 100 transactions across Private Debt, Private Equity, Fundraising, Restructuring and M&A Buy/Sell-Side. Europe based - and gone from large banks to in-house and SMEs and then as distressed investor. happy to answer any questions.
Any thoughts on KKR's Strategic Investment and Capital Solutions Group in London/Europe? Thanks!
How is rx in Europe/UK different from what u see in the US?
How come you never considered public distressed/special sits?
Big picture:
US = single, federal Ch-11 machine.
Europe/UK = mix-and-match rules, so every deal feels bespoke.
⸻
Legal background
• US: Automatic stay, DIP super-priority, §363 sales – debtor runs the show.
• UK: Scheme + new Restructuring Plan (cross-class cram-down, two quick hearings) prepacks more usual.
• Continent: Same idea, 27 flavours.
Negotiations
• Ch-11 lets the company prime liens and roll-ups – lenders blink first.
• Europe: secureds still hold the keys; non-consensual priming is painful to impossible.
Timeline:
• US mega case: 9–18 mths, but playbook is clear.
• UK Plan/Scheme: can be done inside 6–8 wks if everyone’s onside.
• Continental filing: anywhere from “fast-track” to “bring a sleeping bag”.
Capital-structure pricing:
• US: liquid HY + TL-B – price discovery every tick.
• Europe: more bilateral bank/direct-lender paper, lighter trading volume; valuation fights start earlier because screens are blank.
Investor background:
• Stateside: hedge-fund heavy, lots of loan-to-own, litigation angles.
• Europe: fewer pure distressed funds; infra & long-hold PE step in with structured capital.
Private is more active in restructuring and distress. Public distress is mostly price/risk arbitrage mostly. My objective is not to do investing long term.
Looking forward to hearing answers for these - appreciate your time!
1. What are some of the most crucial things distressed investors should keep in mind when assessing a new DistressedCo?
2. What are some of the best distressed investors doing currently that others aren’t?
3. What is the best distressed investment you’ve made, how did it pan out, and what made it remarkable?
On 1:
1. 13-week cash map – end to end and bridge to other 2 FS.
2. Full operations review
3. Full general ledger passed through gril past 5y
4. Stakeholder grid – who owns what and what is their positions and intentions
5. Monetisation scenarios: liquidation vs prepack vs filing vs turnaround vs out of court restru vs sale vs JV
6. Full commercial review for litigation and commercial hidden liabilities.
On 2: caveat as this is my position
1. They start from the run-rate business and what a best in class structure should deliver.
2. They infer the capex and investments required to get there and timeline to cristallise the investment.
3. They go on the other side of the j-curve and check how much pain they will have to go for: legal costs, restru etc and infer the best pathway
On 3: bet on the human and the vision. Anything else is just mechanics.
On the best investment,
It is not the biggest P&L but probably the story I am most proud of.
European SME with less than 3 weeks of runway. Distressed DIP financing -recapitalised to 4 months of runway and transformed 6 months after into a positive fcff business and on track for exit.
Value doubled year on year.
Where do you see Rx activity + distressed/ss investment opportunities heading in next 3 years given impact of tariffs in Europe?
Only negative for Europe is in case of no retaliatory and Chinese escalation.
This could on the short mid term create a tremendous working capital requirement.
Alternatively if not materialised, I see it as a serious opportunity for European special sits and turnarounds.
Thank you for doing this!
My question (sorry, very individual) is: How would you suggest to break into distressed PC/PE while being a non US resident going to H/W/S? Background is Strategy, FIG at a BB and now M&A at a single family office. I'm extremely interested in Rx and turnaraounds and leaving for MBA next year. I would consider any path!
Thanks again!
Thanks - Europe based but hopefully will help. When it comes to MBA - I came from a non restructuring background.
Initially started in Acqfin - lateraled to a Large Cap that almost went under.
Had to restructure the company which was not the plan.
If you want to do restructuring - two options.
The nice way - which you should go for - Rx clubs, calls, case studies, internships.
Or the real way: take anything that is high risk high exposure. Corporate, Fund, etc.
Thanks for your insights! May I ask that for a junior graduate, which pathaway would you recommend to pursue (RX to Special Sits/Distressed, Infra/Energy PE, or LMM/MM PE) considering the end of ZIRP if I'm sure that MFPE is not what I want? This may sound a bit naive but really appreciate for any help!
I think restructuring in itself is overhyped.
If you are not passionate about loan, equity structuring, then don’t go into restructuring which is fundamentally the same.
If I was a graduate I would start by asking myself the questions that really matter: what is the path that I can appreciate the most, and what is the path where I can learn the most.
I think neither private equity or restructuring fits these boxes on the medium term.
If I wanted to simply maximise my knowledge within the first 5 years: I would go do transaction services in a very high deal flow structure at least for some internships or holidays time spent. Then I would do investment banking. Then I would go to a hedge fund.
Then i would just create a business.
Much appreciated for your help!!
I struggle to know what really fascinates me most, though I prefer the story at the corporate finance side rather the fin mkt. But I do prefer the path where I can learn the most.
Why would you prefer TAS-IBD-HF rather than IBD-PE/CorpDev if the final goal is to create a business? The latter seems more in line with the true business side. Thanks to WSO, I've heard another path seems exciting which focus on MM IBD-PE then try to act as independant sponsor or family office PE, where true value hides.
Also in Europe, seems large amount of people in HF starts from ER?
Appreciate for everything you've done here, this really means a lot to a junior guy like me. Really excited about your youtube channel and all the best!
Well, here is my take on this:
IB teaches you an organisation.
Business teaches you to hustle.
The big issue I had in IB (in and out of it) was that it gave an unnecessary status to senior team members although they could be terrible. But the name bubble there is insanely powerful.
And people think 2 year gratification is slow - I say in hindsight it is way too quick when compared to what you need to know in the real world.
So TS has this advantage of being low recognition high stimulation and high application. If you know how to run FDDs and VDDs at a high level and sustain high deal flow for a couple of years, you will make an amazing senior analyst.
Which in turn will make a great associate and then be a «value-add » VP etc.
However I am less convinced by the IB PE path. Do not get me wrong - if you want something plug and play, this is a right way to do. But if I had to put the first type versus second one on a live deal execution - I wouldn’t even think about the second one. Maybe a bit too harsh - but it is the idea.
Lastly on family offices, no. Just don’t enter that space until very late in your career if your goal is to gain knowledge extensively. I have been there - and way too little structure and talent emulation to make it viable below MD level.
Now if you want quality of life and UHNW exposure, it can work.
Hi OP,
Was wondering if it’s quite common to move from distressed credit to equity side? As a fresh grad I’m considering starting at an NPL fund but not sure how hard it would be to transition into equity down the line.
Or is IB still the better choice no matter what?
Thanks for taking the time!
No I would not recommend such a transition at the junior level. Much easier at senior level when focus can be more around portfolio management.
Because your thinking could be logical.
Working in NPL means mostly on the portfolio or loan basket management side: A fund buys SRTs or NPL bundles thus viewing risk and value from a macro or portfolio-level lens. The focus is usually on optimizing recoveries across multiple impaired positions, relying on servicers, legal recovery pathways, or portfolio sales.
In that sense you are trained to assess distressed assets quickly and allocate resources where the recovery ratio justifies it. In this context, you rarely go into the operational depth of each borrower. And rightfully so because you have an army of consultants in your investment case.
Private Equity distressed or turnaround, however requires - at least for their recruitment / or to be a good professional in that space - a very micro, surgical view of each investment. operating a company, managing the - sometimes hostile - capital structure - directly or through governance. That means looking under the hood in all spheres - team quality, margin structure, strategic growth angles, operational levers, stakeholder positions, replacements etc. - and being accountable for long-term transformation.
So while NPL teaches you valuable skills around downside protection, distressed pricing, and legal enforcement, PE demands a step further: operational insight and transformation execution.
In fact, some of the reflexes from NPL (e.g., early exits, bulk deleveraging strategies, minimal engagement) can be in tension with the long-haul, build-to-scale mindset of PE. And thus - this will not support on the mid term a satisfying transition.
However if you are a distress hardcore enthusiast;can be a very good school.
Thanks man, appreciate the elaborate answer - What you said makes complete sense!
Hi thanks for doing this man !
1. What books do you advise for european students aside from gatto and moyer (smthg less ch11 specific). And how can a student improve in distressed investing beyond reading books
2. Do you think it is easy to go from special sits lending (PC-like: rescue capital, dip etc) to tradable distressed ?
3. Whats your take on shops that do distressed real assets (RE, Infra..). Are skills transferrable to corporate credit early in career ?
4. Whats one thing you would have done differently if you had the chance to redo your career in distressed ?
Sorry for spamming and thank you !!
Beyond the classics like Moyer and Gatto, I’d really recommend The Art of M&A series- the normal, distress and modeling one - it’s not necessarily distressed-specific but it gives a strong operational and transactional framework that is super helpful to have a clear understanding of where things may break ahead of going restructuring mode.
That said, there’s honestly nothing more valuable than reading financial news daily and saving every single concept you don’t understand into a folder. Whether it’s a legal clause, instrument structure, process nuance—build your personal “knowledge glossary” and just grind through it. The alternative is to be in a distressed corporate early on but can’t advise that.
Also, I’m currently preparing a curated YouTube channel focused on corporate finance, restructuring, and special situations, tailored for people experiencing those situations. So reverse question to you: if you had the possibility to get such a channel, what would you like to see, what would you resonate with and what platforms would you engage with?
Any person reading this also let me know - so you can help me help you.
It’s possible, but it’s not a like-for-like move and I would definitely do that jump if I want to specialise in investments - not restructure businesses. Special sits lending is tailored by nature: you negotiate your own docs, set your securities, structure your protections and influence the company’s future directly. Every deal is a mini buyout + legal chess match. You’re part-credit, part-operator, part-legal architect and part equity like holder in some cases. Or at least your exposure is.
On the tradable side, you inherit what’s already out there—public bonds, old loans, legacy docs—and your job is to figure out:
(1) how to price the risk vs market misunderstanding,
(2) where you can enforce or get into the cap table, and
(3) whether there’s an angle to reshape the documentation in or out of court or exit profitably.
So: tradable is more about arbitrage, enforcement strategy, and secondary process dynamics. Lending is more about upfront structure, downside protection, and control. Transitioning is doable, but again: at Senior level. And smarter than at junior one long term.
Yes but if you take things knowingly.
If you’re doing distressed real estate with high operational content (e.g. hotel platforms, repositioning logistics hubs, infra turnaround), that’s extremely valuable and maps well to corporate distress. You’re learning capex timing, cost restructuring, margin rebuild, and legal enforcement.
If you’re doing pure collateral-driven plays on low-value-add assets (e.g. residential, no repositioning), the learning curve plateaus faster and I cannot recommend going there long term. So it’s all about the intensity and complexity of the value creation, not just whether there’s collateral or not. For me, collateral plus operational work = as valuable as any corporate credit seat. (And honestly the same if you have the curiosity of understanding the different industries and products)
I would do exactly the same except I wouldn’t make my life hell for it. I would have been more aggressive into it - though for some it’s already a 10/10 risky path.
My path has been pretty unusual. I started in high-yield DCM / acqfin at a top shop. I was a top performer there with the awards etc whatever.
I loved it for two years but quickly became fed up with the politics, and low value add of the service. I didn’t come from a privileged background so anything that was not straight to the point and transformative was utter BS for me.
I got headhunted into an in-house at a top commodity trader that underwent a complete restructuring in house. Company was on brink of collapse and we were 3 people handling multi-billion debt and equity deals, disposals, liquidity crises. Did probably 3 burnouts there and became completely on hedge. But that’s where I understood what most Rx guys never fathom.
Then I became head of M&A in a PE-backed propco that also underwent restructuring, which I had to lead in house.
So by force of things I had to step up.
On the back of this I was recruited by a firm that needed a VP to oversee all special sits / distressed investments.
Built the platform - structured the division and equity vertical by myself - made it to head of investments / MD.
That means I was doing restructurings and recapitalisations hands-on as the advisor, investor, corporate across my career.
So I don’t get affected by the whole prestige BS. Have seen too many fancy investors I had to get out of « tricky » situations.
term sheets, legal docs, CFO meetings, shareholder disputes and operating an asset, enforcing or preventing an enforcement. One can have the fancy pedigree but without the formal toolkit most people get hammered.
I would advise first investment banking then pure Rx - if you are risk averse
I had to learn it backwards. It worked, but it was brutal.
So if I had to redo it: IB first, then operational distress later, with intention.
Thank you for this detailed answer, this is really helpful !!
To answer your question, as a student, I would love to see things that are not easly accessible via a google search or primers: How does RX work in different european nations and what are the pros and cons (why Adler went for a UK RX is a prime example of how can restructurings be different). Maybe detail how an insolvency proceeds in the UK or explain part26A, procédure de Sauvegarde or Sauvegarde Accélérée in France.. I would also love to see explanations for real life case studies. Think any recent RX deals and why did the debtor side advisor opt for one proposition instead of another, it would be great if you could cover Distressed HF POV as well (why did they buy at this time and at this price). I think commenting failed trades and what we can learn from them is even better.
Overall, everything credit/SS related that is not easily googlable (if thats even a word ahaha)
Thank you. Don’t you think that for a student some deep groundwork would be helpful before that?
I am thinking structuring of debt / equity transactions, followed by restructuring techniques, and then local and out of court restructurings.
Yes that would be helpful but you already have a lot of competition. Especially restructuringinterviews dot com that explain in great detail RX, albeit US specific. That’s why I think there might be an interesting opportunity if you do the equivalent for Europe.
Plus, unfortunately most students are interested in IB/PE. There are not many that have an interest in distressed credit/RX and even if they do, most of these are brillant students that are after RX jobs so by definition they already have the basics (that is at least what I observed from my personal experience). Tailoring your work to Analysts 1 or 2 might attract more people and you will surely face less competition.
That said, you can always have the basics/groundwork so that you offer a complete course to those who want to start from 0. Hope that helps
Chiming in here as have had the opportunity to start delivering special sits / distressed content to MBA students at a T10 school. Deep groundwork is absolutely required and don't overestimate how much a student might know. I'm talking you might need to spend a few min bridging revenue to EBITDA to cash conversion and make sure everyone understands things like levered vs unlevered FCF and net working capital dynamics.
For credit and structuring specifically, I think you should spend time (and would have fun doing) breaking down term sheets into their debt models, calculating IRR/MOIC, and decomposing P&L into its return components (OID, cash vs. PIK interest, structuring fee, etc). I think it is really important to not only understand how your return is created, but the reverberations through the corporate model and you would actually be surprised how many junior / mid level professionals struggle to actually build a coherent model from a term sheet...at least on the public side where if you traffic in process special sits / distressed you will need to know this for new money and other events. For example, if you PIK an extra 200bps of interest how much does that help liquidity at the corporate. Say you want a 15% IRR, ok how can you get there in a way that doesn't totally kill your borrower? There are so many levers you can put into a term sheet its ridiculous, truly a sand box (as I say) between OID, heavier PIK vs cash interest, exit economics, FCF sweeps at premiums, warrant coverage, royalties, etc.
For those (me) in the buyside -> distressed corporate camp (LMM to MM), who may have never found themselves drawn by or anticipating this kind of route, but are starting to become more interested - how would you think about positioning yourself (function, company size, must-have experiences, odds, etc)? Is it a matter of going down the operator path until someone taps your shoulder or is there a way to proactively make this happen?
Separately, and since you're in Europe, how hard would it be to move from North America to Europe assuming you have European citizenship and native-level proficiency in a European language?
Mind giving me a bit more background and what you want to do long term?
Law school to LMM PE/Growth to business services Portco as Director then VP of Strategic Initiatives. Restructured Ops and capital structure. Run finance. Coming out of turnaround period now.
I'm generally open and curious to what's open to me - could see myself enjoying the portco route as (eventually) a COO or distressed-focused operating partner but also open to buyside.
My feeling is that making a career of this would require moving to larger, more name-brand platforms where the problems are much more complex.
Currently a junior in Big 4 Turnaround and Restructuring in Europe doing 90-95% liquidations.
How realistic would be to lateral into some fund that do distressed inveating (loan-to-own, DIP lending) or IB RX? The role feels very administrative so feels like there's no hope to even dream about RX/distressed.
What should be my next moves if I want to do the same thing you do. Background: LLB, MiF, no prior IB/M&A experience
Hello,
I would say it depends on how junior.
Big4 turnaround is good if you want to go into tuaeound consulting.
The job is otherwise not fit for pure Rx.
less than 3 months, just started
Gonna add a caveat to this: Big 4 RX is fundamentally different from what traditional RX consulting does (FTI, Alix, A&M etc), atleast in the USA (not sure about Europe, but people stateside reading this should keep that nuance in mind). B4 RX in the USA is wayy more focused on the administrative side (court ordered receiverships etc, as opposed to the "true" RX consulting firms which are more financial / operational.
With that being said, I do believe that Big 4 in Europe have far better exit opps.
Thanks for doing this!
I’m Europe based and about to start a role at an RX IB with heavy deal flow after some years in performing, and I’m keen to do well and learn real skills that will set me up for a career in non-performing, so keen to hear your views on maxing development having worked across the space.
Elsewhere you mention that RX advisory and leaning on brands may not be the best learning experience.
As I look to game-plan my next few years at this shop (and beyond) I’d be keen to understand what you see as the big knowledge gaps people with banker-type training have in your view, and how one could bridge these gaps?
Similarly, if you’ve worked with any advisors who you thought did a good job, I’d be grateful to hear what made certain ones stand out!
You’re about to enter RX at a time when deal flow is strong. That’s a great spot to be in, but the real question is whether you use this momentum to just grind deals, or to actually build range. If you’re aiming for a long-term seat at the table—whether in investing, advisory, or operating turnarounds—you’ve got to make every deal work for you, not just the client.
1. Learning
Most juniors stay at surface level and fail to see the bigger strategy that is made available to them when they see a deck. They are chasing deliverables, updating models, ticking boxes.
You’ll get faster at that, sure. But the people who grow fastest are the ones who start tracking patterns or build their own mental playbook. On every deal, ask yourself:
• What kind of crisis is this? (liquidity vs. solvency vs. governance breakdown)
• Who holds the leverage and why?
• What kind of exit is actually on the table?
Every deal has a logic basically.
Also stay close to cash which is the ultimate Rx bottom line.
Everyone talks about capital structure because fancy and mechanical. But to progress in Rx you need to be laser focused on understanding cash. 13-week cash flows, vendor dynamics, working capital traps, accordion tranches if you know where the cash is bleeding and what levers are real, you’re already ahead.
You also need to progress on Legal as quickly as possible.
You don’t need to be a lawyer, but you do need to have the capacity to challenge an Rx lawyer 6 years down the line. Acceleration clauses, cross-defaults, intercreditor fights, sponsor arbitrages, name it. Learn what triggers action, what are the legal implications and the legal protections and the risk you cannot deploy them. Eventually it is a chess match.
Thirdly understand stakeholder behavior as this is quite underrated.
Some deals are won (or lost) in the room. See how your MD handles fragile founder egos, stressed CFOs, aggressive lenders, passive board members.
2. Gaps You’ll See in Typical Banking Training
Linear and passive thinkers get smoked in Rx up the hierarchy because of lack of understanding in what I said above.
Bankers are trained to optimize for one the cases they know and reproduce a playbook: the base case.
In RX, that mindset gets you behind on every deal as the experienced hustler will always be a step ahead. The best people are running three scenarios at once and thinking in probabilities, not single answers.
Zero operational context.
Most juniors have no idea how businesses actually function day to day. To be good at restructuring you need to manage liabilities sure but you also and mostly manage operational Assets.
3. What Makes Certain Advisors Great
The best RX advisors I’ve worked with both sides of the table are co-building the deal with you and not simply just doing a vague reboot of conversations.
It doesn’t mean they come from fancy shops - actually these guys are the most dangerous because they have high ego and low delivery. Which blows up quite a bit of deals.
So to not do that you need:
1. Fluency across roles: speak to a distressed investor, a CEO, a board member, and a lender - all in the same meeting as if you were one of them - and tailor the pitch without losing substance. That makes them a force multiplier.
2. Ruthless prioritization: know what matters in the deal and not just this week. Not in six months. Push to get your side of the chessboard moving forward.
3. Real backbone in hard situations: everybody gets tense in Rx. Advisors to get paid. Counsels to not get sued. Borrowers to survive and Creditors to protect their name. So the best guys are the ones that always force themselves to keep cool head.
Lastly 4: value-add. If you BS around for 2h on a call I am not dealing with you on another transaction. Embarrassment to everyone on the real world.
Hope this helps!
Thank you - insightful and appreciate the candour! +1SB
Quite early in my career, student right now about to join a RX IB (PJT / HL / Laz) in Europe FT, wanted to know your thoughts on pursuing a JD or a JD MBA in the future? Understand that to some it may be overkill but assume cost isn't an issue and I don't see myself staying in the European distressed space in the long term (language barriers are a key boundary for me), would like a competitive advantage in the US DD space if possible + get more familiarised with US law to be effective at the job.
Thanks again for your time! The notes here have been super helpful to contextualise what i'm getting into / career goals.
Even if you have the wallet, nobody has years to waste.
If your endgame is to work in US RX and you’re using the JD/JD-MBA to bridge into the market, it’s fully overkill unless you’re aiming to practice or do legal-heavy advisory (basically rx counsel).
RX firms in the US hire laterals without JDs —HL, PJT, Laz included and it is quite possible to move within 3 years. Strong Euro RX experience + lateral effort + possibly an internal transfer > 3 years and $300–400k+ sunk into a JD in 99% of cases I consider.
But be mindful no job in Rx houses will give you full legal knowledge. So long as you know the Rx processes, Rx boutiques are pitch heavy and quite high level.
I still need to find a banker that fully redlines an amend and extend themselves.
I did and it cost me years of slaving on office floors.
Is there a large difference in what kind of skillset you learn if you work at a RX shops focused on the Credior side to RX shops focused on the Lendor side?
Yes and no.
It is really much like playing offense and defense on a board game.
Yes because on the debtor side you try to support your business priorities which significantly differ from the lender perspective in most case.
No because you cannot be a good Rx senior banker if you can only manage one side.
No because you asked me the alternative between two paths. And the first included HF so I kept it. But all in all - I do not see the value.
Depending on the business you aim at doing,IBD to PE has little value too versus going TS then IBD and then going from there.
Entrepreneur after IBD is about getting the respect you need. But even this honestly - people won’t really care. Much more valued to have a good business well managed after 3y than doing IBD half motivated if you already know what you want.
Masterpiece
Hi OP, thank you for everything you have done.
Europe based but actually a foreigner, hope to start my career here.
I’ve carefully read the entire post. I used to think that RX, being a highly technical field, would be more suitable for someone like me as a foreigner—since it emphasizes technical requirements and involves less qualitative analysis. After all, I can’t expect to understand European consumer businesses better than locals do.
However, I noticed that you mentioned RX and special sits are overhyped. In that case, do you think generalist IBD(or M&A, Infra, RE..) is actually a better option than RX IBD?
Also, how would you suggest making a choice between Private Investment and Public market? I’m drawn to the true business/operational value of private market/IBD, but HF feels more technically driven, thus more suitable for me?
Thanks a lot for your help.
Thank you for your feedback / reading of the feed —very much appreciated, and hope you got away some useful things as entry points into the European market as a foreigner.
You’re right that RX is often perceived as more technical and structurally oriented, which can seem more “neutral” territory when cultural familiarity is limited.
All in all this remains a common perception 99% of people seem to have so do not take my view as the market’s view. Anything, could be the reverse. I just give my honest view without any sugar coat or attention to prestige.
That said, I’d caution against assuming restructuring it’s inherently a purer technical track—many large restructuring teams, particularly at well-known boutiques, still operate with a pitch-driven, high-level culture. Likewise IBD can be very nurturing if outside of working time you take the very long time of reviewing all the documentation of a deal. But then IBD doesn’t fully allow that because organisation is not efficient and you would jump to 150h / week …
You’ll often find that up to Director level, the depth of execution in Rx can remain quite surface-level unless you actively seek out operational or capital-structure-heavy mandates. The learning curve can be steep, but it’s nonlinear—and standing out at MD level will usually demand exceptional endurance, deal flow generation, which can only be sustained through competence and stamina. It’s not the quiet technical haven some expect.
Everything in IBD / RX is about self learning - from my experience.
On the other hand, while IBD retains a “one-size-fits-all” the generalist model most teams have (even if split in sectors) gives solid foundational exposure but often lacks the space to develop deep expertise unless you actively rotate across capital markets, M&A, and restructuring. Even then, most IBD platforms don’t necessarily allow for deep execution ownership unless you shift laterally or grow into a niche internally.
If you’re drawn to learning curves, complexity, and real business problem-solving, RX can provide sharper inflection points earlier in your career. But it’s important to remain clear-eyed: real technical mastery usually requires moving beyond just branding and into environments where execution, not just deal origination, drives development.
Wishing you strength and clarity in choosing the path that aligns with how you want to grow.
I want to sincerely thank you for your time and thoughtful advice. I'd also like to make sure I’ve understood your points correctly.
What truly matters to me is the opportunity to learn and to gain real operational exposure. Whether it's RX IBD or generalist IBD, the ability to develop those skills largely depends on self-initiative. The only difference is that RX might offer slightly deeper involvement in day-to-day execution. I assume that’s why, in another comment, you suggested that starting in TS could actually be a stronger foundation than IBD.
Your perspective strongly resonates with another great voice I’ve come across on WSO, and I believe it’s because there’s a shared truth: mastering real business operations—not just financial engineering—is what ultimately matters.
That said, do you think an even more learning-rich path might be to break into an operationally-focused LMM/MM PE firm as early as possible, then get deeply involved in portco operations, and then aim to grow into an independent sponsor, or a partner? Or perhaps we could also explore principal investing roles and unique family office setups—places without the classic GP-LP structure, where people have more time and freedom to deepen their knowledge without outside pressure.
Thanks again for this post, it has indeed genuinely reshaped how I think about long-term career development.
Sorry to add a new comment here but your talk with Besoin makes me thinking that, if a junior like me is sure taht what matters is keeping learning the true business world, but not sure about RX, should he still pursue RX just for its complexity and learning curve? Thank you and nice weekend!
Apologies I just saw this - didn’t get notifications.
Appreciate your question - it is a quite complex one without understanding your background.
If you’re genuinely drawn to learning how the business world works under real pressure, RX can offer that - but so can VC or small cap M&A - but the path depends heavily on what you want to build long term.
At this point, the only general recommendation I’d feel confident giving is: if there’s even a seed of ambition to eventually build your own firm, start in the small-cap RX space. Large cap will be too financial engineering driven and you may not be exposed to a full deal.
There you’ll be forced to understand different views of capital providing, strategy, maybe even ops.
Happy to expand in DM to understand your point. It really depends on your endgame.
Have a good week.
Grateful as always, just DM'd you, hope this won't take much of your time. Nice week!
We could also have a call by WSO mentor if that is more convenient for you!
Might not see this, but how feasible is the transition from RX consultng to distressed PE, for both investor and ops roles? Assuming a decent RX consulting shop?
Ut accusantium qui vel ut asperiores pariatur est qui. Distinctio quo et aut.
Ullam quaerat explicabo perspiciatis placeat minima aut incidunt. Sed adipisci dolorem nemo qui voluptatem. Eum ratione laborum impedit autem.
Perspiciatis incidunt modi quis nam cum occaecati. Quis consequatur iure sed ipsum.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Id aut odio accusamus atque. Expedita odit qui illum et rerum debitis reiciendis. Fugiat ut voluptatem dolore. Recusandae aut odio sint qui.
Est eius facere id corporis repellendus est. Modi modi aut ratione autem veritatis enim.
Est qui minima est quod quo delectus temporibus. Exercitationem veniam blanditiis vitae. Doloribus velit inventore minima est sed nostrum voluptate. Voluptatem ut recusandae ea.
Aut vel quia quos tempore voluptatibus. Aliquid est eius iure omnis repudiandae voluptas. Eaque neque distinctio minima laudantium aspernatur non. Consequatur officiis aut quia in nihil. Quidem ex provident earum et ab culpa. Cupiditate sed vero qui voluptatem sequi qui quam impedit. Qui et fugit ex in neque laborum suscipit.
Eaque dolor sunt labore tenetur hic placeat. Doloribus ut sunt itaque consequatur necessitatibus necessitatibus cumque. Quo officiis quibusdam quia deserunt. Corporis autem facere expedita consequatur qui dignissimos et.
Sit repellat similique sed eos sit ratione. Et consequuntur et fugiat dolore sint rerum dolores ex. Numquam illo totam sit voluptatem quam molestias expedita.